Spironolactone Shows Mixed Results in Acute MI ...Middle East

Medscape - News
The mineralocorticoid receptor antagonist did not reduce primary outcomes in the CLEAR SYNERGY trial, but there was a suggestion that it did prevent new or worsening heart failure. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Spironolactone Shows Mixed Results in Acute MI )

Also on site :

Most viewed in News


Latest News